GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › SRZN growth analysis
Growth stock analysis · updated 2026-07-27

Surrozen, Inc. Common (SRZN) growth stock analysis

Is Surrozen, Inc. Common a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
29
Growth score
76
RS rating
#2,356
Rank
1/6
Traits passed
29/99
Growth score · 2356th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about SRZN

As of the 2026-07-27 close, SRZN scores 29 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 2356th of 4,897 rated US stocks, the top 48% of the market.

Its strongest trait is S (supply & demand) at 67, and its weakest is A (annual earnings growth) at 0. SRZN clears 1 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, SRZN carries a middling Relative Strength rating of 76, meaning it has outperformed about 76% of the market over the past year.

Underneath the score: sales up 409%, trading 42% below its 52-week high.

SRZN growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
22
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
10
S
Supply & demand
volume behind the move vs. share supply
67
L
Leader or laggard
Relative Strength within its group
56
I
Institutional sponsorship
fund accumulation and 13F ownership
50

Is SRZN a growth stock?

Not right now by CANSLIM

On today’s data SRZN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than SRZN

The stocks ranking above SRZN today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 SRZN price history & buy range

Where SRZN sits in its base, its 52-week path, and the trait trend over the past year.

Open the full SRZN profile →

See where SRZN ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

SRZN as a growth stock, frequently asked

Is SRZN a good growth stock?

Not right now by CANSLIM. On today’s data SRZN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is SRZN's growth score?

Surrozen, Inc. Common (SRZN) scores 29 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 2356th of 4,897 rated US stocks.

Does SRZN have strong earnings growth?

We don't have current earnings-growth figures for SRZN.

How strong is SRZN's price performance?

SRZN has a Relative Strength rating of 76, meaning it has outperformed roughly 76% of the US market over the trailing year.

Where can I see SRZN's full analysis?

Create a free Growth Stock Analyzer account to see where SRZN ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Biological Products, (No Diagnostic Substances)